VivoSeq
Musculoskeletal

Adhesive Capsulitis

0

Pipeline Programs

5

Active Trials

0

Companies Involved

Adhesive Capsulitis is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

8/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

25

clinical trials

Completed11 · 44%
Unknown status7 · 28%
Recruiting4 · 16%
Terminated1 · 4%
Withdrawn1 · 4%
Not yet recruiting1 · 4%

Trial Activity

25 trials

Dose Efficacy in Adhesive Capsulitis
Recruiting·UUniversity Health Network, Toronto·Phase 3·NCT06848374·40 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)